Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
COLFORM
0341
5
SET
0337
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -195.59%-5.43M | 75.45%58.9M | -5.81M | 71.54M | -5M | -492.26%-1.84M | 127.46%33.57M | 80.26%-2.32M | 103.49%1.79M | 98.66%-310K |
Net profit before non-cash adjustment | -162.75%-406K | -37.11%-15.83M | ---13.96M | ---1.8M | ---727K | 127.73%647K | 92.34%-11.55M | 96.45%-2.65M | 83.72%-8M | 71.08%-2.33M |
Total adjustment of non-cash items | -98.56%12K | 23.74%13.87M | --11.18M | --35K | --1.83M | 18.63%834K | -84.32%11.21M | -99.03%689K | -76.54%11.19M | -81.61%703K |
-Depreciation and amortization | -95.86%12K | -87.44%394.35K | --33.35K | --35K | --36K | -54.55%290K | 6.50%3.14M | -24.85%608K | 123.57%626K | -49.32%638K |
-Reversal of impairment losses recognized in profit and loss | --0 | 1,378.32%8.35M | --8.07M | --0 | --0 | --286K | -101.22%-653.58K | --0 | ---- | ---- |
-Assets reserve and write-off | ---- | -49.75%3.21M | ---- | ---- | ---- | ---- | --6.38M | ---- | ---- | ---- |
-Disposal profit | --0 | -31.57%1.14M | --494 | --0 | --1.07M | --74K | -58.00%1.67M | --0 | ---- | ---- |
-Net exchange gains and losses | ---- | ---190.93K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
-Remuneration paid in stock | ---- | 837.37%933K | --4 | --0 | ---- | ---- | -98.28%99.53K | --18K | -99.37%23K | --0 |
-Other non-cash items | ---- | -94.48%31.71K | --61.71K | --0 | ---214K | 183.08%184K | -88.78%574.63K | -97.89%63K | -78.59%70K | -85.68%65K |
Changes in working capital | -51.73%-5.03M | 79.49%60.86M | ---3.03M | --73.31M | ---6.1M | -351.29%-3.32M | 178.93%33.91M | 95.35%-355K | 97.19%-1.4M | 106.98%1.32M |
-Change in receivables | 99.42%-73K | 502.63%60.23M | ---8.56M | --71.97M | --9.42M | -1,086.77%-12.6M | 113.79%9.99M | 87.43%-3.08M | 79.55%-11.53M | 104.30%1.28M |
-Change in inventory | --0 | -97.98%178.18K | --223.18K | ---24K | ---106K | 110.02%85K | 320.88%8.83M | 96.86%-469K | 146.21%2.85M | -136.16%-848K |
-Change in payables | -153.92%-4.96M | -96.99%453.28K | --5.31M | --1.36M | ---15.41M | 932.44%9.2M | -54.99%15.08M | -89.95%3.19M | -42.92%7.28M | -89.44%891K |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 0 | 0 | 27K | 0 | 0 | -27K | 93.45%-338.26K | |||
Interest received (cash flow from operating activities) | 0 | 0 | 28.57%9K | |||||||
Tax refund paid | -115.66%-196.24K | 124.21%1.25M | 0 | 45.21%-166K | -101.02%-593K | |||||
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | -191.30%-5.43M | 70.22%58.7M | ---5.98M | --71.54M | ---5M | -108.39%-1.86M | 126.01%34.49M | 81.52%-2.32M | 103.14%1.62M | 96.19%-894K |
Investing cash flow | ||||||||||
Capital expenditures | ---- | ---84.29K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net PPE purchase and sale | --0 | 148.16%1.1M | --563K | --0 | --337K | 1,222.22%202K | 5.84%-2.29M | --0 | --0 | 99.68%-18K |
Net business purchase and sale | ---- | -1,149,471.56%-64.1M | --7.9M | ---- | ---- | ---- | 99.98%-5.58K | --0 | ---- | ---- |
Net investment property transactions | ---- | --0 | ---- | ---- | ---- | ---- | 61.14%-27.76M | ---- | ---- | ---- |
Net investment product transactions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
Dividends received (cash flow from investment activities) | ---- | --0 | ---- | ---- | ---- | ---- | -92.25%11.57K | ---- | ---- | ---- |
Interest received (cash flow from investment activities) | ---- | --0 | ---- | ---- | ---- | ---- | -75.42%9.4K | ---- | ---- | ---- |
Investing cash flow | --0 | -110.03%-63.08M | --8.38M | ---72M | --337K | 1,222.22%202K | 71.35%-30.03M | --0 | 99.99%-6K | 99.83%-18K |
Financing cash flow | ||||||||||
Net issuance payments of debt | --0 | ---- | ---- | --0 | --0 | -44.08%-219K | ---- | -256.00%-156K | -27.50%-153K | -131.87%-152K |
Net common stock issuance | --4.4M | 195.09%6.34M | --1.6M | --0 | ---- | ---- | -98.12%2.15M | 6,500.00%1.65M | --0 | -97.00%300K |
Increase or decrease of lease financing | --0 | 71.53%-940.69K | ---763.69K | --0 | --0 | 38.11%-177K | -165.03%-3.3M | -374.19%-294K | -198.64%-290K | 34.70%-286K |
Interest paid (cash flow from financing activities) | ---- | ---26.66K | ---- | ---- | ---- | ---- | --0 | 97.89%-63K | 78.13%-70K | 83.95%-74K |
Net other fund-raising expenses | ---- | 91.61%-264.79K | ---- | ---- | ---- | ---- | -106.84%-3.16M | ---- | ---- | ---- |
Financing cash flow | 1,211.87%4.4M | 218.58%5.11M | --768.23K | --0 | --4.74M | -86.79%-396K | -102.67%-4.31M | 138.93%1.14M | -100.34%-513K | -102.21%-212K |
Net cash flow | ||||||||||
Beginning cash position | 28.95%3.27M | 5.89%2.54M | --103K | --560K | --482K | 5.88%2.54M | -97.07%2.4M | -97.76%2.38M | -97.80%1.27M | -97.07%2.4M |
Current changes in cash | 50.22%-1.02M | 419.89%734.49K | --3.17M | ---457K | --78K | -83.01%-2.06M | 100.19%141.28K | 92.36%-1.18M | -97.74%1.1M | 95.42%-1.12M |
Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 |
End cash Position | 366.80%2.25M | 28.93%3.27M | --3.27M | --103K | --560K | -62.17%482K | 5.89%2.54M | -93.72%1.2M | -97.76%2.38M | -97.80%1.27M |
Free cash flow | -191.30%-5.43M | 90.54%58.62M | ---6.06M | --71.54M | ---5M | -104.28%-1.86M | 122.78%30.77M | 97.47%-2.32M | 103.02%1.62M | 96.87%-912K |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.